Cargando…

A Novel Finding of Lichenoid Drug Reaction From Ibrutinib Therapy

Ibrutinib is Burton’s tyrosine kinase inhibitor used in the treatment of chronic lymphocytic leukemia and other conditions. This drug has been generally thought to be well tolerated, although studies have identified a few distinct adverse effects, including gastrointestinal discomfort, nausea, diarr...

Descripción completa

Detalles Bibliográficos
Autores principales: Reji, Merin, Shah, Kinchit K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941677/
https://www.ncbi.nlm.nih.gov/pubmed/35371696
http://dx.doi.org/10.7759/cureus.22433